Hypertrophic Osteoarthropathy Follow-up

Updated: Jan 13, 2021
  • Author: Vishnuteja Devalla, MD; Chief Editor: Herbert S Diamond, MD  more...
  • Print
Follow-up

Further Outpatient Care

With specific curative treatment for the underlying conditions, secondary hypertrophic osteoarthropathy may remit, with only analgesic and anti-inflammatory supportive treatment required in the meantime. Similarly, the symptomatic recurrences of hypertrophic osteoarthropathy in persons with cystic fibrosis are usually associated with pulmonary superinfections and can be controlled and prevented with appropriate curative or prophylactic antibiotic therapy. In cancer-related cases, a re-emergence of symptoms often heralds disease relapse and may precede symptoms from the primary tumor.

Next:

Inpatient & Outpatient Medications

Any of the classic NSAIDs or a COX-2 inhibitor can be used at their usual dose as needed. These drugs do not influence the evolution of hypertrophic osteoarthropathy, but they are useful to control symptoms. Other analgesic medications (eg, acetaminophen, opioid analgesics) may be used.

Previous
Next:

Prognosis

The mortality and morbidity of hypertrophic osteoarthropathy vary with the associated illness.

Previous
Next:

Patient Education

Patients first diagnosed with hypertrophic osteoarthropathy should be reassured regarding its good prognosis as a musculoskeletal condition. That being established, they should be informed of its significance and the need for further investigation to rule out any treatable associated disease. These investigations are guided by results from thorough clinical evaluations, including questions specifically targeting intrathoracic diseases.

Previous